Oxymetazoline 0.1% w/v


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Check the label for directions before use. Measure it with a marked dropper and take it as directed. XYNOLUBE 0.1% DROPS can be taken it with or without food, although it's advisable to take it consistently at the same time.
XYNOLUBE 0.1% DROPS is a decongestant. It works by narrowing the small blood vessels which provides temporary relief from inflammation (redness and swelling) and discomfort.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with XYNOLUBE 0.1% DROPS . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: XYNOLUBE 0.1% DROPS may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: XYNOLUBE 0.1% DROPS is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. To reduce the amount of XYNOLUBE 0.1% DROPS that reaches the breastmilk, remove the excess solution with an absorbent tissue.
SAFE - XYNOLUBE 0.1% DROPS does not usually affect your ability to drive.
Seek medical advice from your doctor: There is limited information available on the use of XYNOLUBE 0.1% DROPS in patients with kidney disease. Doctor consultation is advised.
Seek medical advice from your doctor: There is limited information available on the use of XYNOLUBE 0.1% DROPS in patients with liver disease. Doctor consultation is advised.
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India
Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 140
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1041-42
Drugs.com. Oxymetazoline (01 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (01 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.